Encompass Health reiterates FY2024 guidance at Barclays conference; no changes

Encompass Health Corp

Company to present at Barclays Global Healthcare Conference on March 12, 2024, with CEO and CFO.
Reaffirms FY2024 guidance: net operating revenue $5,200M-$5,300M.
Adjusted EBITDA reaffirmed at $1,015M-$1,055M; adjusted EPS $3.77-$4.06.
Guidance unchanged from Feb 7 8-K and Feb 8 earnings call.
No new financial or operational updates disclosed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.